Coronavirus

The US Department of Health and Human Services announced that it is expanding an existing collaboration with Regeneron Pharmaceuticals in order to pursue a treatment for the 2019 novel coronavirus.

An article concludes that there has been human-to-human transmission among close contacts since the middle of December 2019.

Gilead Sciences is collaborating with Chinese, US, and global health officials in order to investigate the safety and efficacy of their investigational antiviral compound remdesivir against the novel coronavirus.

The US Food and Drug Administration has authorized the use of a new diagnostic for 2019 novel coronavirus.

Alex Azar has declared a public health emergency in the United States in response to the 2019 novel coronavirus but says the risk to Americans remains low.

As January comes to an end, we’re looking back at important infectious disease news from the past month.

The CDC has also announced the first confirmed non-travel associated case of novel coronavirus in the United States.

The WHO will reconvene on Thursday, January 30, 2020, to discuss whether the novel coronavirus should be designated a public health emergency of international concern.

A new article published in The Lancet features information on epidemiology, laboratory, and radiology elements of the first 41 cases of the novel coronavirus confirmed in Wuhan, China.

The WHO Director-General Tedros Adhanom Ghebreyesus, PhD is not declaring the Wuhan Coronavirus outbreak a Public Health Emergency of International Concern at this time.

The CDC has announced that travelers from Wuhan will undergo entry screening at airports in New York, San Francisco, and Los Angeles.

Infection preventionist Saskia Popescu discusses several rapid developments that have been released in this outbreak.

As of January 5, 2020 there have been 59 confirmed cases associated with the pneumonia outbreak in Wuhan city.

What you should know before you travel this winter season.

A newly identified porcine virus has been found to be able to get into human cells in the laboratory setting.

As healthcare-associated infections continue to be life-threatening, Clorox Healthcare continues to provide bacteria- and virus-killing products that aim to reduce the risk of infection.